Letters
Adverse drug reactions
Reporting guidelines for pharmacoepidemiological studies are urgently needed
BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g5511 (Published 17 September 2014) Cite this as: BMJ 2014;349:g5511
- Mahyar Etminan, drug safety researcher1
- 1Room A4-195, 950 West 28th Avenue, Vancouver, BC, Canada
- metminan{at}popi.ubc.ca
Tan and colleagues discuss factors that contribute to inconsistent information on drug adverse reactions but do not mention the lack of reporting guidelines for pharmacoepidemiological studies.1
Most medical journals require authors to complete checklists that are shortened versions of reporting guidelines, such as CONSORT (randomised trials), PRIMSA (systematic reviews), and …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.